Work

Weight Change from GLP-1 and Lifestyle Therapy in Real-World Pediatric Obesity Care: A Scoping Review

Year: 2026
Type: study-registration
Abstract: This scoping review will map the available real-world evidence on GLP-1 therapy for weight management in children and adolescents younger than 18 years with obesity and/or type 2 diabetes mellitus (T2DM). The review will characterize reported changes in body weight and BMI and examine how outcomes are reported in relation to lifestyle counseling, follow-up duration, clinical monitoring, medication engagement, and tolerability. A scoping review approach will accommodate heterogeneity in study designs, treatment delivery, and outcome reporting while identifying evidence gaps and priorities for future research. Eligible studies will include peer-reviewed observational studies of GLP-1 therapy in pediatric populations with obesity and/or T2DM that report weight or BMI outcomes. Randomized controlled trials, reviews, case reports, grey literature, studies of adults or non-human populations, studies involving intellectual or developmental disabilities, studies evaluating GLP-1 therapy for type 1 diabetes, and studies involving concurrent bariatric surgery will be excluded. The literature search will include PubMed/MEDLINE publications from 2020 through July 2026, supplemented by backward and forward citation searching. Search terms will combine concepts related to adolescents, GLP-1 therapy and specific agents, clinical indications, and observational study designs. Screening will occur in two stages: title and abstract review, followed by full-text review. A single author will conduct screening and document reasons for exclusion. Data will be charted using a structured form capturing study characteristics, population demographics, clinical indications, GLP-1 agents and treatment details, clinical monitoring, follow-up, medication engagement, tolerability, and lifestyle intervention components, including intensive health behavior and lifestyle treatment (IHBLT). Outcomes will include absolute weight change, BMI, BMI z-score, and BMI percentile or other age- and sex-standardized measures. The review will provide a descriptive overview of real-world pediatric GLP-1 research, characterize reported weight outcomes and concurrent lifestyle interventions, and identify gaps in the evidence. Findings are expected to inform future research priorities and support a better understanding of how GLP-1 therapy is implemented within comprehensive pediatric obesity care.
Author: Mary C. Ptak
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W7224253591
Cites:
Cited by:
Related to: 10